Search results

Source:

GOV UK (Add filter)

Source:

Public Health England - PHE (Remove filter)

Published by Public Health England, 02 November 2020

washings should be neutralised by adding approximately 100mg of sodium carbonate to approximately 50mL of the specimen if processing is...

Type:

Policy and Strategy (Remove filter)

Source:

Specialist Pharmacy Service (Remove filter)

20 October 2020

Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Whilst valproate (valproic acid/sodium valproate) is…

Type:

Prescribing and Technical Information (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 30 July 2019

Sections 4.4 and 4.5 have been updated to include information related to trimethoprim-containing products such as cotrimoxazole and other drugs that may increase serum potassium – caution and...

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 08 August 2017

The tablets no longer contain aspartame (E951) or sorbitol (E420). The warning about the use of this product in patients with phenylketonuria has been removed.

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

EUnetHTA (Remove filter)

Published by EUnetHTA, 24 April 2017

The purpose of the assessment is to examine the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in adult patients with treatment-resistant major depression. The...

Read Summary

Type:

Health Technology Assessments (Remove filter)

Source:

Specialist Pharmacy Service (Remove filter)

04 February 2016

Tenofovir alafenamide, a nucleotide reverse transcriptase inhibitor (NtRTI) and prodrug of tenofovir.

Type:

Prescribing and Technical Information (Remove filter)

Source:

Specialist Pharmacy Service (Remove filter)

03 February 2016

A 0.05% ophthalmic emulsion formulation of ciclosporin, a partial immunomodulator and anti-inflammatory agent

Type:

Prescribing and Technical Information (Remove filter)

Source:

Specialist Pharmacy Service (Remove filter)

03 February 2016

Inhibits proliferation of activated T-cells by inhibiting cytokine-mediated signal transduction pathways

Type:

Prescribing and Technical Information (Remove filter)

Source:

Specialist Pharmacy Service (Remove filter)

21 January 2016

Angiogenesis inhibitor

Type:

Prescribing and Technical Information (Remove filter)

Source:

Specialist Pharmacy Service (Remove filter)

21 January 2016

Dibenzazepine derivative with anti-epileptic, neurotropic and psychotropic properties

Type:

Prescribing and Technical Information (Remove filter)